OpenAlex
PricingAboutJobs
Log inGet started
Work

Efficacy and Tolerability of Once-Daily Extended Release Quetiapine Fumarate in Acute Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study

HTML

Year: 2007
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Journal of Clinical Psychiatry
DOI: 10.4088/jcp.v68n0603
Authors: René S. Kahn, S. Charles Schulz, Veselin D. Palazov, Efren B. Reyes, Martin Brecher, Ola Svensson, Henrik M. Andersson, Didier Meulien
Institutions: AstraZeneca (United Kingdom), Utrecht University, University Medical Center Utrecht, AstraZeneca (Sweden), National Center for Mental Health
Language: English

Topic: Schizophrenia research and treatment
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Keywords: quetiapine, sustained-release formulation, acute schizophrenia, once-daily dosing, antipsychotic efficacy, tolerability, extrapyramidal symptoms, dose escalation, sleepiness, dizziness, adverse events, treatment-emergent adverse events, antipsychotic switching
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2072344162
FWCI: 5.406
Cites:
Cited by: 113
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security